Nagasaki Akira, Kato Yoshio, Meguro Keiichi, Yamagishi Ayana, Nakamura Chikashi, Uyeda Taro Q P
Biomedical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), 1-1-1 Higashi, Tsukuba, Ibaraki 305-8565, Japan.
Biomedical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), 1-1-1 Higashi, Tsukuba, Ibaraki 305-8565, Japan.
Plasmid. 2018 Jun;98:37-44. doi: 10.1016/j.plasmid.2018.08.005. Epub 2018 Sep 6.
The CRISPR/Cas9 system is a powerful genome editing tool for disrupting the expression of specific genes in a variety of cells. However, the genome editing procedure using currently available vectors is laborious, and there is room for improvement to obtain knockout cells more efficiently. Therefore, we constructed a novel vector for high efficiency genome editing, named pGedit, which contains EGFP-Bsr as a selection marker, expression units of Cas9, and sgRNA without a terminator sequence of the U6 promoter. EGFP-Bsr is a fusion protein of EGFP and blasticidin S deaminase, and enables rapid selection and monitoring of transformants, as well as confirmation that the vector has not been integrated into the genome. By using pGedit, we targeted human ACTB, ACTG1 and mouse Nes genes coding for β-actin, γ-actin and nestin, respectively. Knockout cell lines of each gene were easily and efficiently obtained in all three cases. In this report, we show that our novel vector, pGedit, significantly facilitates genome editing.
CRISPR/Cas9系统是一种强大的基因组编辑工具,可用于破坏多种细胞中特定基因的表达。然而,使用现有载体进行基因组编辑的过程较为繁琐,在更高效地获得基因敲除细胞方面仍有改进空间。因此,我们构建了一种用于高效基因组编辑的新型载体,命名为pGedit,它含有作为选择标记的EGFP-Bsr、Cas9表达单元以及不含U6启动子终止序列的sgRNA。EGFP-Bsr是EGFP与杀稻瘟菌素S脱氨酶的融合蛋白,能够快速筛选和监测转化体,并确认载体未整合到基因组中。通过使用pGedit,我们分别靶向了编码β-肌动蛋白、γ-肌动蛋白和巢蛋白的人类ACTB、ACTG1基因以及小鼠Nes基因。在所有三种情况下,均轻松且高效地获得了每个基因的敲除细胞系。在本报告中,我们表明我们的新型载体pGedit显著促进了基因组编辑。